Skip to main content

Table 2 Values on measures amongst participants in the observation phase at each time point

From: Evaluation of a smartwatch-based intervention providing feedback of daily activity within a research-naive stroke ward: a pilot randomised controlled trial

Outcome Baseline 3 weeks 12 weeks/3 months
M (SD) Median (range) M (SD) Median (range) M (SD) Median (range)
Performance-based
 Grip strength (Kg)
  Right 17 (12.4)   18 (13.7)    
  Left 14 (11.4)   12 (12.3)    
 10-m walk test (s) 41 (28.4)   52 (52.7)    
 MoCA 14 (6.2) 13 (4–26) 17 (4.8) 18 (7–25)   
 BI 11 (4.5) 10 (4–20) 11 (3.5) 11 (6–17)   
Self-report
 FSS   43 (15–63)   51 (11–61)   
 VAF-S   6 (0–10)   7 (2–10)   
 EQ-5D-5L VAS 57 (26.2) 60 (10–100) 59 (26.8) 65 (0–100) 56 (16.5) 60 (30–85)
 RMI   6 (1–14)   8 (1–12)   9 (0–15)
 WHODAS   45 (18–83)   53 (33–77)   44 (12–100)
  1. Data were included only if the patient successfully completed assessment.
  2. Abbreviations: MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index; FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale; EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health Organization Disability Assessment Schedule (12-item). M (SD), mean and standard deviation. WHODAS scores represent a percentage of the maximum disability score (the total score, between 0 and 48, is divided by 48 and multiplied by 100)